Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)

NCT00072046 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

732

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: recombinant interferon alfa

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]